OTC · Biotechnology

Affymax, Inc. (AFFY) Stock

$0.00 OTC: AFFY Healthcare

Affymax, Inc. presently lacks any substantial operational activities.

Valuation

MetricValue
Price$0.00
Market Cap$37490
P/E Ratio0.00
P/B Ratio0.01
P/S Ratio0.89
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE111.59%
ROA-228.91%
ROCE750.00%
Gross Margin497.62%
Operating Margin-1500.00%
Net Margin-1400.00%
Debt/Equity0.00
Current Ratio20.81

Annual Financials (USD)

Metric20092010201120122013
Revenue$115.0M$113.0M$48.0M$94.0M$1.0M
Operating Profit$-79.0M$-14.0M$-61.0M$-92.0M$-15.0M
Net Profit$-77.0M$-14.0M$-61.0M$-93.0M$-14.0M
EPS$-4.06$-0.57$-1.84$-2.57$-0.39
Op Margin-68.7%-12.8%-128.7%-97.5%-1099.0%

Balance Sheet (USD)

Metric20092010201120122013
Total Assets$212.0M$131.0M$119.0M$118.0M$7.0M
Total Liabilities$145.0M$59.0M$43.0M$110.0M$9.0M
Cash$125.0M$63.0M$54.0M$68.0M$6.0M
Borrowings$9.0M$0$0$9.0M$0

Cash Flow (USD)

Metric20092010201120122013
Operating Cash Flow$-81.0M$-49.0M$-72.0M$-37.0M$-67.0M
Investing Cash Flow$48.0M$-12.0M$7.0M$21.0M$14.0M
Financing Cash Flow$0$0$0$12.0M$0
Net Cash Flow$101.0M$-62.0M$-9.0M$14.0M$-63.0M
Free Cash Flow$-82.0M$-50.0M$-73.0M$-41.0M$-67.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.39
FCF Yield-179618.56%
Quick Ratio0.71
Interest Coverage-9.61
Return 1Y25.00%
Return 3Y-76.74%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Ancora Advisors, LLC5002023-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMBSAmarantus BioScience Holdings, Inc. $0.00 — -0.01 $36841 0.00%
BSSPBaseline Productions, Inc. $0.00 — -0.02 $74377 0.00%
CNBXCNBX Pharmaceuticals Inc. $0.00 — 0.10 $9251 0.00%
ENDVEndonovo Therapeutics, Inc. $0.00 — 1.00 $31875 0.00%
GNLKQGeneLink, Inc. $0.00 — 0.00 $10601 0.00%

About Affymax, Inc.

Affymax, Inc. presently lacks any substantial operational activities. In its earlier history, the firm concentrated on the creation of pharmaceutical agents designed to improve therapies for severe and frequently fatal health issues across the United States. Established in 2001, its corporate base is situated in New York, New York.

Affymax, Inc. (AFFY) stock trades at $0.00 with a market capitalization of $37490. The stock is valued at price-to-book of 0.01, price-to-sales of 0.89.

On profitability, Affymax, Inc. generates a return on equity (ROE) of 111.59%, above the typical market range of roughly 12-15%, return on capital employed of 750.00%, an operating margin of -1500.00%, a net profit margin of -1400.00%.

Official website: www.affymax.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.